Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 31007 | 129 | 36.5 | 90% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 56 | 28576 | CHOLESTERYL ESTER TRANSFER PROTEIN//JOURNAL OF LIPID RESEARCH//HIGH DENSITY LIPOPROTEIN |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | APOLIPOPROTEIN M | Author keyword | 78 | 83% | 34% | 44 |
| 2 | APOM | Author keyword | 55 | 92% | 17% | 22 |
| 3 | COMPREHENS | Address | 3 | 18% | 12% | 16 |
| 4 | COMPETENCE INTEGRATED HUMAN PHYSIOL | Address | 2 | 67% | 2% | 2 |
| 5 | SECT CLIN CHEM PHARMACOL | Address | 2 | 27% | 5% | 7 |
| 6 | AFFILIATED TAIXING PEOPLES HOSP | Address | 1 | 100% | 2% | 2 |
| 7 | AFFILITED HOSP 3 | Address | 1 | 50% | 1% | 1 |
| 8 | ANHUI PROV BIOL MACROMOL | Address | 1 | 50% | 1% | 1 |
| 9 | APO M | Author keyword | 1 | 50% | 1% | 1 |
| 10 | DBLDB MOUSE | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | APOLIPOPROTEIN M | 78 | 83% | 34% | 44 | Search APOLIPOPROTEIN+M | Search APOLIPOPROTEIN+M |
| 2 | APOM | 55 | 92% | 17% | 22 | Search APOM | Search APOM |
| 3 | APO M | 1 | 50% | 1% | 1 | Search APO+M | Search APO+M |
| 4 | DBLDB MOUSE | 1 | 50% | 1% | 1 | Search DBLDB+MOUSE | Search DBLDB+MOUSE |
| 5 | HDL BASED THERAPIES | 1 | 50% | 1% | 1 | Search HDL+BASED+THERAPIES | Search HDL+BASED+THERAPIES |
| 6 | HIGH DENSITY LIPOPROTEIN BIOGENESIS | 1 | 50% | 1% | 1 | Search HIGH+DENSITY+LIPOPROTEIN+BIOGENESIS | Search HIGH+DENSITY+LIPOPROTEIN+BIOGENESIS |
| 7 | SIALYLATIONS | 1 | 50% | 1% | 1 | Search SIALYLATIONS | Search SIALYLATIONS |
| 8 | OBLOB MOUSE | 0 | 33% | 1% | 1 | Search OBLOB+MOUSE | Search OBLOB+MOUSE |
| 9 | FINRISK | 0 | 25% | 1% | 1 | Search FINRISK | Search FINRISK |
| 10 | HEPATIC INTRAARTERIAL CHEMOTHERAPY | 0 | 25% | 1% | 1 | Search HEPATIC+INTRAARTERIAL+CHEMOTHERAPY | Search HEPATIC+INTRAARTERIAL+CHEMOTHERAPY |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | APOM | 72 | 100% | 18% | 23 |
| 2 | M GENE EXPRESSION | 49 | 94% | 13% | 17 |
| 3 | BETA HDL FORMATION | 27 | 92% | 9% | 11 |
| 4 | APOLIPOPROTEIN M | 5 | 29% | 12% | 15 |
| 5 | APOLIPOPROTEIN M EXPRESSION | 2 | 67% | 2% | 2 |
| 6 | M EXPRESSION | 1 | 23% | 4% | 5 |
| 7 | NUCLEAR RECEPTOR LRH 1 | 1 | 25% | 2% | 3 |
| 8 | LIPOPROTEIN PATTERNS | 1 | 50% | 1% | 1 |
| 9 | MHC CLASS III | 1 | 50% | 1% | 1 |
| 10 | UREMIC MICE | 1 | 50% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Apolipoprotein M in lipid metabolism and cardiometabolic diseases | 2015 | 1 | 81 | 41% |
| Characteristics of apolipoprotein M and its relation to atherosclerosis and diabetes | 2010 | 10 | 45 | 73% |
| Apolipoprotein M: bridging HDL and endothelial function | 2013 | 11 | 55 | 35% |
| Apolipoprotein M - a novel player in high-density lipoprotein metabolism and atherosclerosis | 2006 | 20 | 22 | 59% |
| LXR-Agonists Regulate ApoM Expression Differentially in Liver and Intestine | 2008 | 10 | 13 | 69% |
| Apolipoprotein M affecting lipid metabolism or just catching a ride with lipoproteins in the circulation? | 2009 | 12 | 38 | 50% |
| Apolipoprotein M: Progress in understanding its regulation and metabolic functions | 2006 | 10 | 20 | 70% |
| Apolipoprotein M: Research progress, regulation and metabolic functions (Review) | 2015 | 0 | 75 | 75% |
| The Apolipoprotein M-Sphingosine-1-Phosphate Axis: Biological Relevance in Lipoprotein Metabolism, Lipid Disorders and Atherosclerosis | 2013 | 8 | 62 | 31% |
| ApoM: gene regulation and effects on HDL metabolism | 2009 | 11 | 37 | 46% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | COMPREHENS | 3 | 18% | 12% | 16 |
| 2 | COMPETENCE INTEGRATED HUMAN PHYSIOL | 2 | 67% | 1.6% | 2 |
| 3 | SECT CLIN CHEM PHARMACOL | 2 | 27% | 5.4% | 7 |
| 4 | AFFILIATED TAIXING PEOPLES HOSP | 1 | 100% | 1.6% | 2 |
| 5 | AFFILITED HOSP 3 | 1 | 50% | 0.8% | 1 |
| 6 | ANHUI PROV BIOL MACROMOL | 1 | 50% | 0.8% | 1 |
| 7 | SHANGHAI 1ST PEOPLES HOSP | 1 | 50% | 0.8% | 1 |
| 8 | WALLENBERG UNIV HOSP | 1 | 50% | 0.8% | 1 |
| 9 | METAB DIABET NEPHROL | 1 | 25% | 1.6% | 2 |
| 10 | INTERNAL MED VET AFFAIRS | 0 | 33% | 0.8% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000126494 | TORCETRAPIB//HIGH DENSITY LIPOPROTEIN//ANACETRAPIB |
| 2 | 0.0000120281 | APOLIPOPROTEIN D//APOLIPOPROTEIN D APOD//APOD |
| 3 | 0.0000094187 | SPHINGOSINE 1 PHOSPHATE//FTY720//SPHINGOSINE KINASE |
| 4 | 0.0000086736 | ABCA1//TANGIER DISEASE//ATP BINDING CASSETTE TRANSPORTER A1 |
| 5 | 0.0000082934 | MODY//MATURITY ONSET DIABETES OF THE YOUNG//MATURITY ONSET DIABETES OF THE YOUNG MODY |
| 6 | 0.0000075800 | APOLIPOPROTEIN A IV//APOA IV//CHILDRENS FDN MEMPHIS |
| 7 | 0.0000074044 | LIPOPROT UNIT//LIPOPROTEIN KINETICS//OURCE IL KINET ANAL |
| 8 | 0.0000066938 | LIVER X RECEPTOR//LXR//LIVER X RECEPTORS |
| 9 | 0.0000062394 | ALLOGRAFT INFLAMMATORY FACTOR 1//AIF 1//DAINTAIN AIF 1 |
| 10 | 0.0000057671 | APOLIPOPROTEIN A I//REVERSE CHOLESTEROL TRANSPORT//APOLIPOPROTEIN A II |